K2 HealthVentures Equity Trust LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | K2 HealthVentures Equity Trust LLC | 2,873 0.020% | -339,240 (-99.16%) | Filing |
| 2024-02-14 4:45 pm Purchase | 2023-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | K2 HealthVentures Equity Trust LLC | 342,113 7.500% | 342,113 (New Position) | Filing |